Karyopharm Therapeutics Inc. · 2 days ago
Summer Intern – Finance & IT
Newton, MA
Internship
Hybrid
Intern
$22/hr - $30/hrKaryopharm Therapeutics Inc. is a biotech company focused on pioneering novel cancer therapies. They are seeking a motivated Finance/IT Intern to support financial and operational activities, providing unique visibility into the finance function while working closely with the CFO on various projects.
Health CareMedicalPharmaceutical
Responsibilities
Assist with preparation of monthly and quarterly financial forecasts
Update financial models, templates, and dashboards as needed
Help compile data for executive presentations and board materials
Assist with monthly close activities such as accrual preparation, journal entry support, and data reconciliation
Help gather and organize supporting documentation for account reconciliations
Help maintain AP aging schedules and follow up on outstanding items
Conduct research, financial analysis, and benchmarking for CFO-driven strategic initiatives
Assist in preparing materials for senior leadership meetings and special reviews
Take on ad hoc assignments that require strong problem-solving and data analysis skills
Research AI tools, automation solutions, and efficiency technologies relevant to finance processes
Evaluate budgeting, forecasting, and planning system options; assist with vendor comparison and ROI analysis
Support preliminary research for potential upgrades to financial general ledger systems (e.g., workflows, integrations, cost structures)
Help document requirements, summarize findings, and make recommendations to the IT team, the CFO and Finance team
Qualification
Required
Must be able to complete the Karyopharm internship Program 27 May – 08 Aug 2025
Currently enrolled high school or college (bachelor's program) student
Student must be returning to school in the Fall Term
Must have a minimum GPA of 3.0
Must be highly organized and have the ability to work independently and collaboratively as a team
Clear, concise verbal & written communication
Company
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Founded in 2008
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$607.2MKey Investors
Avidity PartnersForesite CapitalDelphi Ventures
2025-10-08Post Ipo Equity· $33M
2025-10-08Post Ipo Debt· $27.5M
2022-12-05Post Ipo Equity· $165M
Leadership Team
Brian Austad
Senior Vice President, Pharmaceutical Sciences
Sohanya Cheng
EVP, Chief Commercial Officer & Head of Business Development
Recent News
2025-11-08
Company data provided by crunchbase